(Q38092916)

English

A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines

scientific article published on 26 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

Jacek Jassem

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

author name string

Mario Campone

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Natalya Dobrovolskaya

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Serjei Tjulandin

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Shin-Chen Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sameul Fourie

5

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Fawzia Mefti

6

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Maria Konstantinova

7

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Florence Lefresne

8

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Nadege Meheust

9

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

publication date

26 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

The Breast Journal

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

240-249

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Optimizing the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FTBJ.12098

21 January 2018

Identifiers

10.1111/TBJ.12098

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38092916&oldid=1740834382"